KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $587,000 | +18.6% | 7,790 | -21.0% | 0.11% | +25.0% |
| Q1 2015 | $495,000 | +44.7% | 9,861 | 0.0% | 0.09% | +60.0% |
| Q4 2014 | $342,000 | +5.9% | 9,861 | 0.0% | 0.06% | +34.1% |
| Q3 2014 | $323,000 | -6.1% | 9,861 | +9.9% | 0.04% | +13.9% |
| Q2 2014 | $344,000 | -3.6% | 8,971 | 0.0% | 0.04% | -12.2% |
| Q1 2014 | $357,000 | -5.3% | 8,971 | -11.2% | 0.04% | -14.6% |
| Q4 2013 | $377,000 | -18.0% | 10,097 | 0.0% | 0.05% | -35.1% |
| Q3 2013 | $460,000 | +68.5% | 10,097 | 0.0% | 0.07% | +37.0% |
| Q2 2013 | $273,000 | – | 10,097 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |